Table 1.
Comparison of TCRγGR Results in Cell Lines and Tumor Specimens by Two Methods
| A: Cell lines | DGGE | CE | Variable gene segment | Joining gene segment | ||
|---|---|---|---|---|---|---|
| Status | No. RR | Status | No. RR | |||
| CEM | pos | 2 | pos | 2 | Vγ3, Vγ4 | 2-Jγ1/Jγ2 |
| HSB2 | pos | 2 | pos | 2 | Vγ9, Vγ10 | 2-Jγ1/Jγ2 |
| 8402 | pos | 2 | pos | 2 | Vγ4, Vγ10 | 2-Jγ1/Jγ2 |
| MOLT4 | pos | 2 | pos | 2 | Vγ2, Vγ10 | 2-JγP1/JγP2 |
| Jurkat | pos | 2 | pos | 2 | Vγ8, Vγ11 | 2-Jγ1/Jγ2 |
| Cell line totals B: Clinical specimens | 5/5 | 10/10 | 5/5 | 10/10 | ||
| Selected TCRγGR positive cases for validation set | 25/25 | 31/31 | 23/25 | 28/31 | ||
| Total: All TCRγGR | 30/30 | 41/41 | 28/30 | 38/41 | ||
CE, capillary electrophoresis; DGGE, denaturing gradient gel electrophoresis; No., number; RR, individual rearrangements per case may be 1 or more; pos, positive, Status, clonal for TCRγGR.